4.6 Article

Innate Sensing of Foamy Viruses by Human Hematopoietic Cells

期刊

JOURNAL OF VIROLOGY
卷 86, 期 2, 页码 909-918

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.06235-11

关键词

-

类别

资金

  1. Agence Nationale de Recherche sur le SIDA (ANRS)
  2. Agence Nationale de Recherche (ANR)
  3. SIDACTION
  4. CNRS
  5. AREVA
  6. Institut Pasteur
  7. Centre d'Immunologie Humaine at the Institut Pasteur

向作者/读者索取更多资源

Foamy viruses (FV) are nonpathogenic retroviruses that have cospeciated with primates for millions of years. FV can be transmitted through severe bites from monkeys to humans. Viral loads remain generally low in infected humans, and no secondary transmission has been reported. Very little is known about the ability of FV to trigger an innate immune response in human cells. A few previous reports suggested that FV do not induce type I interferon (IFN) in nonhematopoietic cells. Here, we examined how human hematopoietic cells sense FV particles and FV-infected cells. We show that peripheral blood mononuclear cells (PBMCs), plasmacytoid dendritic cells (pDCs), and the pDC-like cell line Gen2.2 detect FV, produce high levels of type I IFN, and express the IFN-stimulated gene MxA. Fewer than 20 FV-infected cells are sufficient to trigger an IFN response. Both prototypic and primary viruses stimulated IFN release. Donor cells expressing a replication-defective virus, carrying a mutated reverse transcriptase, induced IFN production by target cells as potently as wild-type virus. In contrast, an FV strain with env deleted, which does not produce viral particles, was inactive. IFN production was blocked by an inhibitor of endosomal acidification (bafilomycin A1) and by an endosomal Toll-like receptor (TLR) antagonist (A151). Silencing experiments in Gen2.2 further demonstrated that TLR7 is involved in FV recognition. Therefore, FV are potent inducers of type I IFN by pDCs and by PBMCs. This previously underestimated activation of the innate immune response may be involved in the control of viral replication in humans.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Hematology

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma

Soledad Henriquez, Jeremie Zerbit, Timothee Bruel, Amani Ouedrani, Delphine Planas, Paul Deschamps, Isabelle Staropoli, Jerome Hadjadj, Bruno Varet, Natalia Ermak, Didier Bouscary, Lise Willems, Guillemette Fouquet, Justine Decroocq, Patricia Franchi, Benedicte Deau-Fischer, Benjamin Terrier, Jerome Tamburini, Lucienne Chatenoud, Olivier Schwartz, Marguerite Vignon

Article Multidisciplinary Sciences

Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells

Jeremy Dufloo, Cyril Planchais, Stephane Fremont, Valerie Lorin, Florence Guivel-Benhassine, Karl Stefic, Nicoletta Casartelli, Arnaud Echard, Philippe Roingeard, Hugo Mouquet, Olivier Schwartz, Timothee Bruel

Summary: Researchers have found that broadly neutralizing antibodies (bNAbs) can not only neutralize HIV-1, but also block the release of viral particles by trapping them on the surface of infected cells. This study reveals an additional antiviral mechanism of bNAbs.

NATURE COMMUNICATIONS (2022)

Article Microbiology

Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals

Mathieu Hubert, Florence Guivel-Benhassine, Timothee Bruel, Francoise Porrot, Delphine Planas, Jessica Vanhomwegen, Aurelie Wiedemann, Sonia Burrel, Stephane Marot, Romain Palich, Gentiane Monsel, Harouna Diombera, Sebastien Gallien, Jose Luis Lopez-Zaragoza, William Vindrios, Fabien Taieb, Sandrine Fernandes-Pellerin, Maurine Delhaye, Helene Laude, Laurence Arowas, Marie-Noelle Ungeheuer, Laurent Hocqueloux, Valerie Pourcher, Thierry Prazuck, Anne-Genevieve Marcelin, Jean-Daniel Lelievre, Christophe Batejat, Yves Levy, Jean-Claude Manuguerra, Olivier Schwartz

Summary: The third generation modified vaccinia Ankara (MVA) vaccine is effective in preventing MPXV infection. The levels of neutralizing antibodies (NAbs) are influenced by age and previous smallpox vaccination history.

CELL HOST & MICROBE (2023)

Editorial Material Immunology

Pathogen metabolite checkpoint: NHR on guard

Rejane Rua, Nathalie Pujol

Summary: In this study, researchers discovered that a specific metabolite can be recognized by Caenorhabditis elegans, leading to the activation of detoxifying enzymes and immunity-related genes through binding with a nuclear hormone receptor, thus protecting the worm from pathogenic bacteria.

IMMUNITY (2023)

Article Immunology

Novel mouse models based on intersectional genetics to identify and characterize plasmacytoid dendritic cells

Michael Valente, Nils Collinet, Thien-Phong Vu Manh, Dimitri Popoff, Khalissa Rahmani, Karima Naciri, Gilles Bessou, Rejane Rua, Laurine Gil, Cyrille Mionnet, Pierre Milpied, Elena Tomasello, Marc Dalod

NATURE IMMUNOLOGY (2023)

Article Multidisciplinary Sciences

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies

Delphine Planas, Timothee Bruel, Isabelle Staropoli, Florence Guivel-Benhassine, Francoise Porrot, Piet Maes, Ludivine Grzelak, Matthieu Prot, Said Mougari, Cyril Planchais, Julien Puech, Madelina Saliba, Riwan Sahraoui, Florent Femy, Nathalie Morel, Jeremy Dufloo, Rafael Sanjuan, Hugo Mouquet, Emmanuel Andre, Laurent Hocqueloux, Etienne Simon-Loriere, David Veyer, Thierry Prazuck, Helene Pere, Olivier Schwartz

Summary: Convergent evolution of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 lineages have led to the emergence of several new subvariants, including BA.2.75.2, BA.4.6, and BQ.1.1. These subvariants carry additional mutations in the spike protein, potentially increasing transmissibility and evading immune responses. The study found that the efficacy of monoclonal antibodies and serum from vaccinated individuals against these subvariants varies.

NATURE COMMUNICATIONS (2023)

Review Immunology

Polyfunctionality of broadly neutralizing HIV-1 antibodies

Lou-Lena Vrignaud, Olivier Schwartz, Timothee Bruel

Summary: The discovery of broadly neutralizing HIV-1 antibodies (bNAbs) has provided new hope for vaccine design and cure of HIV-1 infection. These antibodies not only recognize the HIV-1 Envelope and inhibit viral fusion, but also activate immune cells and interfere with viral spread through nonneutralizing activities. This review focuses on the landscape of bNAbs functions and their contribution to clinical efficacy.

CURRENT OPINION IN HIV AND AIDS (2023)

Article Microbiology

Exposure to Secreted Bacterial Factors Promotes HIV-1 Replication in CD4+ T Cells

M. Znaidia, Y. de Souza-Angelo, S. Letoffe, I. Staropoli, L. Grzelak, J. M. Ghigo, O. Schwartz, N. Casartelli

Summary: Microbial translocation is associated with systemic immune activation in HIV-1 disease. Some bacteria can activate T cells and enhance HIV-1 replication, suggesting a role of bacterial factors in promoting T cell activation and HIV-1 replication.

MICROBIOLOGY SPECTRUM (2023)

Article Biochemical Research Methods

Flow cytometry and immunohistochemistry of the mouse dural meninges for immunological and virological assessments

Annie Roussel-Queval, Julie Rebejac, Elisa Eme-Scolan, Laurie Arnaud Paroutaud, Rejane Rua

Summary: This article presents techniques for the immunological and virological assessment of mouse dural meninges. It includes steps for immunophenotyping and viral assessment upon lymphocytic choriomeningitis virus infection.

STAR PROTOCOLS (2023)

Article Pharmacology & Pharmacy

Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis

Guillaume Lingas, Delphine Planas, Helene Pere, Francoise Porrot, Florence Guivel-Benhassine, Isabelle Staropoli, Darragh Duffy, Nicolas Chapuis, Camille Gobeaux, David Veyer, Constance Delaugerre, Jerome Le Goff, Prunelle Getten, Jerome Hadjadj, Adele Bellino, Beatrice Parfait, Jean-Marc Treluyer, Olivier Schwartz, Jeremie Guedj, Solen Kerneis, Benjamin Terrier

Summary: This study analyzed the kinetics of neutralizing antibody levels during acute infection with the alpha variant and showed that increases in neutralizing antibodies led to a shorter half-life of infected cells and infectious viral particles, resulting in rapid viral clearance. Simulation studies predicted that a high neutralizing activity could significantly reduce the risk of detectable viral load and infectiousness.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

Review Immunology

Meningeal regulation of infections: A double-edged sword

Elisa Eme-Scolan, Laurie Arnaud-Paroutaud, Narjess Haidar, Annie Roussel-Queval, Rejane Rua

Summary: Important discoveries have been made in the field of neuroimmunology, specifically regarding the role of meninges in brain infection and cognitive disorders. This review discusses the protective role of meningeal layers in the central nervous system against various infections and explores the neurological consequences of meningeal infections in both neonates and adults. The aim is to provide an integrated view of meningeal immune regulations and their impact on CNS infections and neurological outcomes.

EUROPEAN JOURNAL OF IMMUNOLOGY (2023)

Article Virology

SARS-CoV-2 replicates in the human testis with slow kinetics and has no major deleterious effects ex vivo

Dominique Mahe, Salome Bourgeau, Janaina da Silva, Julie Schlederer, Anne-Pascale Satie, Nadege Kuassivi, Romain Mathieu, Yves-Marie Guillou, Anna Le Tortorec, Florence Guivel-Benhassine, Olivier Schwartz, Ingrid Plotton, Nathalie Dejucq-Rainsford

Summary: This study demonstrates that SARS-CoV-2 can infect testicular cells in an ex vivo model, but the virus replication is slow and has minimal impact on testicular morphology and hormonal functions, suggesting that direct deleterious effects of SARS-CoV-2 on the testes are unlikely.

JOURNAL OF VIROLOGY (2023)

Article Multidisciplinary Sciences

Dissecting human population variation in single-cell responses to SARS-CoV-2

Yann Aquino, Aurelie Bisiaux, Zhi Li, Mary O'Neill, Javier Mendoza-Revilla, Sarah Helene Merkling, Gaspard Kerner, Milena Hasan, Valentina Libri, Vincent Bondet, Nikaia Smith, Camille de Cevins, Mickael Menager, Francesca Luca, Roger Pique-Regi, Giovanna Barba-Spaeth, Stefano Pietropaoli, Olivier Schwartz, Geert Leroux-Roels, Cheuk-Kwong Lee, Kathy Leung, Joseph T. Wu, Malik Peiris, Roberto Bruzzone, Laurent Abel, Jean-Laurent Casanova, Sophie A. Valkenburg, Darragh Duffy, Etienne Patin, Maxime Rotival, Lluis Quintana-Murci

Summary: Humans exhibit significant individual clinical variability after SARS-CoV-2 infection, and the genetic and immunological basis for this variability is being studied. In this study, researchers analyzed single-cell RNA sequencing data from 222 healthy donors with diverse ancestries, who were exposed to SARS-CoV-2 or influenza A virus. They found that SARS-CoV-2 induces weaker but more heterogeneous immune responses compared to influenza A virus, and identified population differences in transcriptional responses to viruses driven by changes in cell composition. The study also highlights the impact of genetic variants on immune responses and the role of natural selection in population differences. Furthermore, they uncover the cellular and molecular mechanisms by which Neanderthal introgression has influenced immune functions. Additionally, the researchers reveal an overlap between the genetic basis of immune responses to SARS-CoV-2 and COVID-19 severity, shedding light on the factors contributing to disparities in COVID-19 risk.

NATURE (2023)

Article Multidisciplinary Sciences

RUFY3 regulates endolysosomes perinuclear positioning, antigen presentation and migration in activated phagocytes

Remy Char, Zhuangzhuang Liu, Cedric Jacqueline, Marion Davieau, Maria-Graciela Delgado, Clara Soufflet, Mathieu Fallet, Lionel Chasson, Raphael Chapuy, Voahirana Camosseto, Eva Strock, Rejane Rua, Catarina R. Almeida, Bing Su, Ana-Maria Lennon-Dumenil, Beatrice Nal, Antoine Roquilly, Yinming Liang, Stephane Meresse, Evelina Gatti, Philippe Pierre

Summary: This study shows that iRUFY3 plays a role in perinuclear positioning, phagocyte migration and antigen presentation during Salmonella infection. iRUFY3 controls macrophages migration, MHC II presentation and responses to Interferon-γ, while being important for intracellular Salmonella replication.

NATURE COMMUNICATIONS (2023)

Article Infectious Diseases

Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021

Tom Woudenberg, Laurie Pinaud, Laura Garcia, Laura Tondeur, Stephane Pelleau, Alix De Thoisy, Francoise Donnadieu, Marija Backovic, Mikael Attia, Nathanael Hoze, Cecile Duru, Aymar Davy Koffi, Sandrine Castelain, Marie-Noelle Ungeheuer, Sandrine Fernandes Pellerin, Delphine Planas, Timothee Bruel, Simon Cauchemez, Olivier Schwartz, Arnaud Fontanet, Michael White

Summary: The aim of this study was to develop a method that predicts virus neutralisation and disease protection based on variant-specific antibody measurements to SARS-CoV-2 antigens. Using a prediction model, the researchers were able to estimate population immunity and determine the vulnerability of individuals with different types of immunity. The results showed the importance of vaccination in providing strong protection against symptomatic or severe COVID-19.

EUROSURVEILLANCE (2023)

暂无数据